Role of Vascular Inflammation in Coronary Artery Disease: Potential of Anti-inflammatory Drugs in the Prevention of Atherothrombosis
Carregando...
Citações na Scopus
103
Tipo de produção
article
Data de publicação
2015
Editora
ADIS INT LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
MOREIRA, Daniel Medeiros
SILVA, Roberto Leo da
FATTAH, Tammuz
LUENEBERG, Maria Emilia
GOTTSCHALL, Carlos Antonio Mascia
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, v.15, n.1, p.1-11, 2015
Resumo
Coronary artery disease (CAD) and acute myocardial infarction (AMI) are inflammatory pathologies, involving interleukins (ILs), such as IL-1 beta, IL-6 and tumor necrosis factor (TNF)-alpha, and acute phase proteins production, such as for C reactive protein (CRP). The process begins with retention of low-density lipoprotein (LDL) and its oxidation inside the intima, with the formation of the ""foam cells."" Toll-like receptors and inflamassomes participate in atherosclerosis formation, as well as in the activation of the complement system. In addition to innate immunity, adaptive immunity is also associated with atherosclerosis through antigen-presenting cells, T and B lymphocytes. AMI also increases the expression of some ILs and promotes macrophage and lymphocyte accumulation. Reperfusion increases the expression of anti-inflammatory ILs (such as IL-10) and generates oxygen free radicals. Although CAD and AMI are inflammatory disorders, the only drugs with anti-inflammatory effect so far widely used in ischemic heart disease are aspirin and statins. Some immunomodulatory or immunosuppressive promising therapies, such as cyclosporine and colchicine, may have benefits in CAD. Methotrexate also has potential cardioprotective anti-inflammatory effects, through increased adenosine levels. The TETHYS trial (The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS trial) will evaluate low-dose methotrexate in ST elevation AMI. The CIRT (Cardiovascular Inflammation Reduction Trial), in turn, will evaluate low-dose methotrexate in patients with a high prevalence of subclinical vascular inflammation. The CANTOS (The Canakinumab Antiinflammatory Thrombosis Outcomes Study) will evaluate canakinumab in patients with CAD and persistently elevated CRP. The blockage of other potential targets, such as the IL-6 receptor, CC2 chemokine receptor and CD20, could bring benefits in CAD.
Palavras-chave
Referências
- Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155
- Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014
- Anderson JL, 2013, CIRCULATION, V127, pE663, DOI 10.1161/CIR.0b013e31828478ac
- [Anonymous], 2014, N ENGL J MED, V370, P1702
- Baigent C, 2002, BRIT MED J, V324, P71
- Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43
- Asanuma H, 2004, J CARDIOVASC PHARM, V43, P574, DOI 10.1097/00005344-200404000-00013
- Avina-Zubieta JA, 2013, RHEUMATOLOGY, V52, P68, DOI 10.1093/rheumatology/kes353
- BAGGOTT JE, 1986, BIOCHEM J, V236, P193
- Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
- BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238
- Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479
- BOBRYSHEV YV, 1995, ARCH HISTOL CYTOL, V58, P307, DOI 10.1679/aohc.58.307
- Bonvini RF, 2005, EUR HEART J SUPPL, V7, pI27, DOI 10.1093/eurheartj/sui077
- Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598
- Bulgarelli A, 2013, CARDIOVASC DRUG THER, V27, P531, DOI 10.1007/s10557-013-6488-3
- Bulgarelli A, 2012, J CARDIOVASC PHARM, V59, P308, DOI 10.1097/FJC.0b013e318241c385
- Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272
- Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONHA.105.590018
- Chiu B, 1997, CIRCULATION, V96, P2144
- Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2
- Crisby M, 2013, ANGIOLOGY
- CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884
- CRONSTEIN BN, 1991, P NATL ACAD SCI USA, V88, P2441, DOI 10.1073/pnas.88.6.2441
- CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440
- Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3
- Duilio C, 2001, AM J PHYSIOL-HEART C, V280, pH2649
- Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/01.CIR.0000012489.17433.31
- Engstrom G, 2007, EUR J CARDIOV PREV R, V14, P392, DOI 10.1097/01.hjr.0000244582.30421.b2
- Everett BM, 2013, AM HEART J, V166, pe115
- Ferdinandy P, 2000, CIRC RES, V87, P241
- Fihn SD, 2012, CIRCULATION, V126, pE354, DOI 10.1161/CIR.0b013e318277d6a0
- FOREMAN KE, 1994, J CLIN INVEST, V94, P1147, DOI 10.1172/JCI117430
- Frangogiannis NG, 2000, J IMMUNOL, V165, P2798
- Frangogiannis NG, 2002, AM J PATHOL, V160, P1425, DOI 10.1016/S0002-9440(10)62568-0
- Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8
- Gabay C, 1999, NEW ENGL J MED, V340, P448
- Gilbert J, 2011, AM J CARDIOL, V107, P906, DOI 10.1016/j.amjcard.2010.11.005
- Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
- Grad E, 2011, AM J PHYSIOL-HEART C, V301, pH730, DOI 10.1152/ajpheart.00067.2011
- Grundtman C, 2011, ARTERIOSCL THROM VAS, V31, P960, DOI 10.1161/ATVBAHA.110.217877
- Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2
- Hamaguchi Y, 2005, J IMMUNOL, V174, P4389
- Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10
- HEINRICH PC, 1990, BIOCHEM J, V265, P621
- Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X
- Hudson MP, 2006, J AM COLL CARDIOL, V48, P15, DOI 10.1016/j.jacc.2006.02.055
- Ikonomidis I, 1999, CIRCULATION, V100, P793
- Incalcaterra E, 2013, CURR ATHEROSCLER REP, V15, P1
- Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367
- Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7
- Karakas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051441
- Kerekes G, 2009, CLIN RHEUMATOL, V28, P705, DOI 10.1007/s10067-009-1095-1
- KLEINDIENST R, 1993, AM J PATHOL, V142, P1927
- Krychtiuk KA, 2013, HAMOSTASEOLOGIE, V33, P269, DOI 10.5482/HAMO-13-07-0039
- KUKIELKA GL, 1993, J CLIN INVEST, V92, P1504, DOI 10.1172/JCI116729
- Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200
- Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033
- Kyaw T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029371
- Kyaw T, 2011, CURR OPIN LIPIDOL, V22, P373, DOI 10.1097/MOL.0b013e32834adaf3
- Kyaw T, 2011, CIRC RES, V109, P830, DOI 10.1161/CIRCRESAHA.111.248542
- Kyaw T, 2013, CIRCULATION, V127, P1028, DOI 10.1161/CIRCULATIONAHA.112.001347
- Laine P, 2002, AM J CARDIOL, V90, P404, DOI 10.1016/S0002-9149(02)02498-0
- LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340
- Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158
- Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108
- MADIAS JE, 1982, CIRCULATION, V65, P1106
- Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2
- Morabito L, 1998, J CLIN INVEST, V101, P295, DOI 10.1172/JCI1554
- Moreira Daniel Medeiros, 2009, J Card Fail, V15, P828, DOI 10.1016/j.cardfail.2009.06.439
- Moreira DM, 2013, CARDIOLOGY, V126, P167, DOI 10.1159/000351972
- Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2
- Musial J, 2001, INT J CARDIOL, V77, P247, DOI 10.1016/S0167-5273(00)00439-3
- Naitza S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002480
- Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383
- Nicholls SJ, 2013, JAMA-J AM MED ASSOC, V311, P252
- NICULESCU F, 1987, CLIN EXP IMMUNOL, V69, P477
- Nidorf SM, 2013, J AM COLL CARDIOL, V61, P404, DOI 10.1016/j.jacc.2012.10.027
- Niessner A, 2006, CIRCULATION, V114, P2482, DOI 10.1161/CIRCULATIONAHA.106.642801
- O'Donoghue ML, 2014, JAMA-J AM MED ASSOC, V312, P1006, DOI 10.1001/jama.2014.11061
- O'Gara PT, 2013, CIRCULATION, V2013, pe362
- Oksjoki R, 2007, ATHEROSCLEROSIS, V192, P40, DOI 10.1016/j.atherosclerosis.2006.06.013
- OKUSAWA S, 1988, J EXP MED, V168, P443, DOI 10.1084/jem.168.1.443
- Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847
- Pasceri V, 2000, CIRCULATION, V102, P2165
- Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142
- Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765
- Ramirez JA, 1996, ANN INTERN MED, V125, P979
- Reiss AB, 2001, J LIPID RES, V42, P1913
- Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC
- Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012
- Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556
- Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
- Ridker PM, 1999, CIRCULATION, V99, P1161
- Ridker PM, 2000, CIRCULATION, V101, P1767
- Rokitansky KF, 1852, AUFLAGERUNG EINIGE W, P3
- Roubille F, 2014, AM J CARDIOVASC DRUG, V14, P73, DOI 10.1007/s40256-013-0049-9
- Sage AP, 2012, ARTERIOSCL THROM VAS, V32, P1573, DOI 10.1161/ATVBAHA.111.244731
- Saraste A, 1997, CIRCULATION, V95, P320
- Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4
- Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784
- Song L, 2001, J CLIN INVEST, V108, P251, DOI 10.1172/JCI11380
- Speidl WS, 2011, FASEB J, V25, P35, DOI 10.1096/fj.10-156083
- Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963
- Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890
- Takahashi T, 2008, CIRC J, V72, P867, DOI 10.1253/circj.72.867
- Tardif JC, 2008, LANCET, V371, P1761, DOI 10.1016/S0140-6736(08)60763-1
- Tardif JC, 2010, CIRC-CARDIOVASC IMAG, V3, P298, DOI 10.1161/CIRCIMAGING.110.937169
- Terkeltaub RA, 2009, SEMIN ARTHRITIS RHEU, V38, P411, DOI 10.1016/j.semarthrit.2008.08.006
- Testa L, 2008, J THORAC CARDIOV SUR, V136, P884, DOI 10.1016/j.jtcvs.2007.12.062
- Trelle S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7086
- Weis M, 2002, ARTERIOSCL THROM VAS, V22, P1817, DOI 10.1161/01.ATV.0000036418.04998.D5
- Weiss SM, 1996, J INFECT DIS, V173, P957
- Westlake SL, 2010, RHEUMATOLOGY, V49, P295, DOI 10.1093/rheumatology/kep366
- WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551
- WITZTUM JL, 1994, LANCET, V344, P793
- Yilmaz A, 2004, ATHEROSCLEROSIS, V176, P101, DOI 10.1016/j.atheroscclerosis.2004.04.027
- Zhou XH, 2000, CIRCULATION, V102, P2919